Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-014869

SVP, Chief Business Officer sold 6,357 shares at $3.03 ($19,257)

  • SVP, Chief Business Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mitchener Stephen · SVP, Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-28 Grant or award : show line 1 in the form +60,000 134,670 D
2023-03-01 Sale : show line 2 in the form −6,357 $3.03 $19,257 128,313 D
Open-market sales · 6,357 sh · avg $3.03 · $19,257
Loading xslF345X03/doc4.xml…